Tower Research Capital LLC (Trc) Teva Pharmaceutical Industries LTD Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 29,619 shares of TEVA stock, worth $507,077. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,619
Previous 3,099
855.76%
Holding current value
$507,077
Previous $50,000
966.0%
% of portfolio
0.01%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding TEVA
# of Institutions
624Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$736 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$620 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$591 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$494 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$454 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...